Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation

Hania Kebir, Katharina Kreymborg, Igal Ifergan, Aurore Dodelet-Devillers, Romain Cayrol, Monique Bernard, Fabrizio Giuliani, Nathalie Arbour, Burkhard Becher, Alexandre Prat*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1394 Scopus citations

Abstract

TH17 lymphocytes appear to be essential in the pathogenesis of numerous inflammatory diseases. We demonstrate here the expression of IL-17 and IL-22 receptors on blood-brain barrier endothelial cells (BBB-ECs) in multiple sclerosis lesions, and show that IL-17 and IL-22 disrupt BBB tight junctions in vitro and in vivo. Furthermore, TH17 lymphocytes transmigrate efficiently across BBB-ECs, highly express granzyme B, kill human neurons and promote central nervous system inflammation through CD4+ lymphocyte recruitment.

Original languageEnglish (US)
Pages (from-to)1173-1175
Number of pages3
JournalNature Medicine
Volume13
Issue number10
DOIs
StatePublished - Oct 2007

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation'. Together they form a unique fingerprint.

Cite this